G G Gibson - JoVE Visualize

Showing results (51-60 of 82) with videos related to

Pageof 9

Sort By:

Toxicology|April 27, 2000

Use of suppression-PCR subtractive hybridisation to identify genes that demonstrate altered expression in male rat and guinea pig livers following exposure to Wy-14,643, a peroxisome proliferator and non-genotoxic hepatocarcinogenJ C Rockett, K E Swales, D J Esdaile, et al.

Biochemical Pharmacology|March 1, 1988

Lack of evidence for a hepatic peroxisome proliferator receptor and an explanation for the binding of hypolipidaemic drugs to liver homogenatesM N Milton, C R Elcombe, G E Kass, et al.

Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|June 1, 1986

In vitro metabolism of teratogens by differentiating rat embryo cellsL P Brown, O P Flint, T C Orton, et al.

Biochemical Pharmacology|September 15, 1985

Immunochemical study on the contribution of hypolipidaemic-induced cytochrome P-452 to the metabolism of lauric acid and arachidonic acidS K Bains, S M Gardiner, K Mannweiler, et al.

Archives of Toxicology|January 1, 1994

Induction of hepatic microsomal CYP4A activity and of peroxisomal beta-oxidation by two non-steroidal anti-inflammatory drugsE Rekka, E O Ayalogu, D F Lewis, et al.

Biochemical Pharmacology|September 1, 1990

Characterization of the hepatic responses to the short-term administration of ciprofibrate in several rat strain. Co-induction of microsomal cytochrome P-450 IVA1 and peroxisome proliferationJ M Makowska, C Anders, P S Goldfarb, et al.

The Journal of Steroid Biochemistry and Molecular Biology|December 13, 2002

Molecular modelling of the human glucocorticoid receptor (hGR) ligand-binding domain (LBD) by homology with the human estrogen receptor alpha (hERalpha) LBD: quantitative structure-activity relationships within a series of CYP3A4 inducers where induction is mediated via hGR involvementD F V Lewis, M S Ogg, P S Goldfarb, et al.

The Biochemical Journal|June 15, 1990

Induction of cytochrome P450III and P450IV family proteins in streptozotocin-induced diabetesC R Barnett, G G Gibson, C R Wolf, et al.

Journal of Biochemical Toxicology|January 1, 1992

Influence of single and concurrent clofibrate and phenobarbital administration on cytochrome P450-dependent mixed function oxidase activities and peroxisome proliferation in male rat liverI Close, G Shackleton, P S Goldfarb, et al.

Toxicology and Applied Pharmacology|April 1, 1989

Cysteine conjugate beta-lyase of rat kidney cytosol: characterization, immunocytochemical localization, and correlation with hexachlorobutadiene nephrotoxicityM MacFarlane, J R Foster, G G Gibson, et al.

Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:

Pageof 9

Toxicology|April 27, 2000

Use of suppression-PCR subtractive hybridisation to identify genes that demonstrate altered expression in male rat and guinea pig livers following exposure to Wy-14,643, a peroxisome proliferator and non-genotoxic hepatocarcinogenJ C Rockett, K E Swales, D J Esdaile, et al.

Biochemical Pharmacology|March 1, 1988

Lack of evidence for a hepatic peroxisome proliferator receptor and an explanation for the binding of hypolipidaemic drugs to liver homogenatesM N Milton, C R Elcombe, G E Kass, et al.

Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|June 1, 1986

In vitro metabolism of teratogens by differentiating rat embryo cellsL P Brown, O P Flint, T C Orton, et al.

Biochemical Pharmacology|September 15, 1985

Immunochemical study on the contribution of hypolipidaemic-induced cytochrome P-452 to the metabolism of lauric acid and arachidonic acidS K Bains, S M Gardiner, K Mannweiler, et al.

Archives of Toxicology|January 1, 1994

Induction of hepatic microsomal CYP4A activity and of peroxisomal beta-oxidation by two non-steroidal anti-inflammatory drugsE Rekka, E O Ayalogu, D F Lewis, et al.

Biochemical Pharmacology|September 1, 1990

Characterization of the hepatic responses to the short-term administration of ciprofibrate in several rat strain. Co-induction of microsomal cytochrome P-450 IVA1 and peroxisome proliferationJ M Makowska, C Anders, P S Goldfarb, et al.

The Journal of Steroid Biochemistry and Molecular Biology|December 13, 2002

Molecular modelling of the human glucocorticoid receptor (hGR) ligand-binding domain (LBD) by homology with the human estrogen receptor alpha (hERalpha) LBD: quantitative structure-activity relationships within a series of CYP3A4 inducers where induction is mediated via hGR involvementD F V Lewis, M S Ogg, P S Goldfarb, et al.

The Biochemical Journal|June 15, 1990

Induction of cytochrome P450III and P450IV family proteins in streptozotocin-induced diabetesC R Barnett, G G Gibson, C R Wolf, et al.

Journal of Biochemical Toxicology|January 1, 1992

Influence of single and concurrent clofibrate and phenobarbital administration on cytochrome P450-dependent mixed function oxidase activities and peroxisome proliferation in male rat liverI Close, G Shackleton, P S Goldfarb, et al.

Toxicology and Applied Pharmacology|April 1, 1989

Cysteine conjugate beta-lyase of rat kidney cytosol: characterization, immunocytochemical localization, and correlation with hexachlorobutadiene nephrotoxicityM MacFarlane, J R Foster, G G Gibson, et al.

Pageof 9